Navigation Links
New England Cord Blood Bank chooses Sepax 2 from Biosafe as their Cord Blood Processing Platform
Date:9/18/2012

NEWTON, Mass., Sept. 18, 2012 /PRNewswire/ -- New England Cord Blood Bank, Inc. (NECBB) is pleased to announce that it now processes its cord blood using the Sepax 2 system from Biosafe.  Biosafe is the world leader in stem cell processing, serving stem cell banks, hospitals and research institutes alike with innovative cell processing solutions. 

Sepax 2 is a fully automated, mobile, closed capability system that provides the most efficient and consistent processing of umbilical cord blood. According to Brad Blaney, Laboratory Manager at NECBB, "From the day Sepax 2 was integrated into the lab, we saw a reduction in processing time and therefore an increase in our processing capacity.  The reliability, repeatability, and ease of use of the devices is great." The system involves processing of the umbilical cord blood via both its "plasma depletion" method and the "red cell reduction" method.  The Sepax system provides the NECBB client with exceptional post-thaw cell viability count.  This ensures that your family will have the greatest supply of high quality stem cells available should transplant become necessary.  Sepax processes every cord blood unit individually, respecting its biologic specificity and unique cell characteristics.

New England Cord Blood Bank, Inc. (NECBB) and its parent company, New England Cryogenic Center, Inc. have been pioneering forces in the cryogenic preservation of cells for over 30 years. At its International Headquarters, located just outside of Boston, Massachusetts, NECBB processes and stores lifesaving stem cells for thousands of families worldwide. Cord blood stem cells, obtained from the umbilical cord immediately following birth, are currently used to treat and cure more than 80 diseases. Successful transplants for cancer, anemia and other blood based diseases occur on a regular basis at approved transplant hospitals both domestically and internationally.

Most recently, families have begun to also bank the cord tissue itself. This tissue contains regenerative stem cells that have the potential to repair virtually any tissue in the human body. NECBB is proud to offer the processing of the cord tissue, at no additional cost, when families bank their child's cord blood at NECBB. 

New England Cord Blood Bank can be reached 24 hours per day at 1-888-700-2673 or visit their site at www.cordbloodbank.com.


'/>"/>
SOURCE New England Cord Blood Bank
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
2. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
3. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
4. New England Biolabs Demonstrates Support for Interactive Scientific Literature by Collaborating with AQnowledge
5. New England Biolabs Develops Novel Polymerase with Ultra-High Fidelity and Minimal GC Bias
6. FindTheBest Helps Parents Find Cord Blood Banks
7. Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
8. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
9. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
10. Study finds chronic abnormal brain blood flow in Gulf War veterans
11. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
Breaking Biology News(10 mins):